Extrapulmonary Tuberculosis in Cirrhosis: Too Familiar-Too Much Unknown.
作者信息
Dahale Amol S, Puri Amarender S, Verma Anushka, Sachdeva Sanjeev, Dalal Ashok, Banerjee Debabrata
机构信息
Department of Medical Gastroenterology, Dr DY Patil Medical College, Pune, India.
Department of Medical Gastroenterology, GIPMER, New Delhi, India.
出版信息
J Clin Exp Hepatol. 2022 May-Jun;12(3):1021-1022. doi: 10.1016/j.jceh.2021.12.004. Epub 2021 Dec 8.
Abstract
摘要
相似文献
1
Extrapulmonary Tuberculosis in Cirrhosis: Too Familiar-Too Much Unknown.
J Clin Exp Hepatol. 2022 May-Jun;12(3):1021-1022. doi: 10.1016/j.jceh.2021.12.004. Epub 2021 Dec 8.
2
Tuberculosis in Cirrhosis - A Diagnostic and Management Conundrum.
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):278-286. doi: 10.1016/j.jceh.2021.09.003. Epub 2021 Sep 10.
3
Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis.
J Clin Exp Hepatol. 2015 Mar;5(1):8-13. doi: 10.1016/j.jceh.2015.01.003. Epub 2015 Jan 27.
4
[Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
Mikrobiyol Bul. 2012 Oct;46(4):689-94.
5
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
J Assoc Physicians India. 2006 Mar;54:219-34.
6
Two findings of portal hypertension: evaluation of correlation between serum-ascites albumin gradient and esophageal varices in non-alcoholic cirrhosis.
Turk J Gastroenterol. 2003 Dec;14(4):219-22.
7
Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis.
World J Gastroenterol. 2012 Oct 7;18(37):5260-5. doi: 10.3748/wjg.v18.i37.5260.
8
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.
Lancet Respir Med. 2018 Apr;6(4):265-275. doi: 10.1016/S2213-2600(18)30078-X.
9
Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
Monaldi Arch Chest Dis. 2004 Jan-Mar;61(1):65-70.
10
Use of adenosine deaminase (ADA) to diagnose suspected peritoneal tuberculosis in Rwanda: a cross-sectional study.
BMC Infect Dis. 2020 Mar 20;20(1):239. doi: 10.1186/s12879-020-04965-0.
本文引用的文献
1
Tuberculosis in Cirrhosis - A Diagnostic and Management Conundrum.
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):278-286. doi: 10.1016/j.jceh.2021.09.003. Epub 2021 Sep 10.
2
Reappraisal of the Role of Ascitic Fluid Adenosine Deaminase for the Diagnosis of Peritoneal Tuberculosis in Cirrhosis.
Korean J Gastroenterol. 2021 Sep 25;78(3):168-176. doi: 10.4166/kjg.2021.068.
3
Clinical and biochemical profile of tuberculosis in patients with liver cirrhosis.
J Clin Exp Hepatol. 2015 Mar;5(1):8-13. doi: 10.1016/j.jceh.2015.01.003. Epub 2015 Jan 27.
4
A guide to the management of tuberculosis in patients with chronic liver disease.
J Clin Exp Hepatol. 2012 Sep;2(3):260-70. doi: 10.1016/j.jceh.2012.07.007. Epub 2012 Sep 21.
5
Prevalence of tuberculosis in patients with cirrhosis of liver in western India.
Trop Doct. 2010 Jul;40(3):163-4. doi: 10.1258/td.2010.090463. Epub 2010 May 17.
6
Anorectal tuberculosis.
Proc R Soc Med. 1969 Dec 12;62(12):1227-30. doi: 10.1177/003591576906201214.
Zotero 插件